Antiviral activities of ISG20 in positive-strand RNA virus infections
about
The antiviral protein viperin inhibits hepatitis C virus replication via interaction with nonstructural protein 5AThe yin and yang of hepatitis C: synthesis and decay of hepatitis C virus RNAInnate immune responses in hepatitis C virus infectionDynamic imaging of the hepatitis C virus NS5A protein during a productive infection.Interferon stimulated exonuclease gene 20 kDa links psychiatric events to distinct hepatitis C virus responses in human immunodeficiency virus positive patients.An interferon response gene signature is associated with the therapeutic response of hepatitis C patientsMultiple low-dose challenges in a rhesus macaque AIDS vaccine trial result in an evolving host response that affects protective outcomeTRIM56 is a virus- and interferon-inducible E3 ubiquitin ligase that restricts pestivirus infectionAn interferon-beta promoter reporter assay for high throughput identification of compounds against multiple RNA viruses.The Broad-Spectrum Antiviral Protein ZAP Restricts Human RetrotranspositionStabilization of hepatitis C virus RNA by an Ago2-miR-122 complex.Interferon-stimulated genes and their antiviral effector functionsCell-intrinsic innate immune control of West Nile virus infection.Interferon-inducible ribonuclease ISG20 inhibits hepatitis B virus replication through directly binding to the epsilon stem-loop structure of viral RNAEmerging roles of interferon-stimulated genes in the innate immune response to hepatitis C virus infectionGenome-wide profiling of in vivo LPS-responsive genes in splenic myeloid cells.Interferon-stimulated gene of 20 kDa protein (ISG20) degrades RNA of hepatitis B virus to impede the replication of HBV in vitro and in vivo.Interferon-stimulated gene 20-kDa protein (ISG20) in infection and disease: Review and outlookLinks between recognition and degradation of cytoplasmic viral RNA in innate immune response.Influenza A Virus-induced expression of ISG20 inhibits viral replication by interacting with nucleoprotein.Transcriptional Repression of IFN Regulatory Factor 7 by MYC Is Critical for Type I IFN Production in Human Plasmacytoid Dendritic CellsOverlapping and distinct molecular determinants dictating the antiviral activities of TRIM56 against flaviviruses and coronavirus.Thiazolides Elicit Anti-Viral Innate Immunity and Reduce HIV Replication.Interferon regulated gene (IRG) expression-signature in a mouse model of chikungunya virus neurovirulence.Interferon-Stimulated Gene (ISG)-Expression Screening Reveals the Specific Antibunyaviral Activity of ISG20.Interferon-stimulated gene 20 kDa protein serum levels and clinical outcome of hepatitis B virus-related liver diseases.Identification of Feline Interferon Regulatory Factor 1 as an Efficient Antiviral Factor against the Replication of Feline Calicivirus and Other Feline Viruses.The Interferon-Induced Exonuclease ISG20 Exerts Antiviral Activity through Upregulation of Type I Interferon Response ProteinsFoot-and-mouth disease virus induces lysosomal degradation of NME1 to impair p53-regulated interferon-inducible antiviral genes expression
P2860
Q24632380-23AEA443-227B-493D-AA6E-4C54867FEC97Q26800446-EE431068-C25A-450D-8621-D8C2AC39B01CQ27023055-510C75F1-3C35-476A-9586-786F40B132F4Q30576516-B55EFB17-C3B3-4DD1-A627-3722696ADC91Q33968365-981E25DA-B986-4296-9694-0DEB43838396Q34027569-93CB8E94-7B58-4003-A813-D8A2CBB771A9Q34593105-52CBC240-859B-4910-9D1C-2FE013EFDF97Q35076566-566ACBAA-6C69-4CE2-A5DC-F75CEB5280C5Q35162433-BA487302-AEC6-461C-B861-AB51BEBAA251Q35639494-014777FA-39E8-48C1-8A84-A16B13E269D7Q35735135-56B530D4-9C3A-4297-B621-AB7A5643C47AQ35742006-E7270856-6990-49C1-A017-A66369FD64A0Q36287746-31154D98-AC0B-43C1-AC03-FA6AC9805FF0Q36343335-C2DED095-ED9F-4413-AF0D-841B605347AFQ36460968-1AC7B621-769A-458E-8A80-C996548DABC6Q37462198-9044E412-2A74-4791-8CC9-19D74837036EQ37708772-A70DEC5B-D3A9-4FB3-B2E4-2414F52D97E4Q37712675-C4BE855B-2F6F-46B5-92C6-7E2DBA214264Q38661444-C358C019-9724-4C9E-B3A7-9793B12CA73DQ38735261-7AB2D5FB-0AD9-4358-BDAB-00E844AD8C99Q38746231-7AE5A074-0041-42CC-AFB5-7E5F0D778872Q38953548-C1D7150C-51B4-42B8-8C5D-8E3057C854D6Q39717911-A4258CA3-3BC7-44C9-9BD7-F60C61034A11Q44843636-53CDB46F-94AE-4DD9-A79F-10E2A79857A6Q52563024-A40CAB8B-CDFA-4306-8C0D-013D0EB6BD1FQ55402079-CE44B65E-A4C2-460F-9158-12BC3D47731CQ55715334-C92C04F6-0B8A-4080-B522-C9E17C2D1E0BQ57010734-B24FB92C-A374-4A58-B119-2E2DC03ADAB1Q58695696-6CB7164B-FB27-471F-8F17-49046C8A7D6B
P2860
Antiviral activities of ISG20 in positive-strand RNA virus infections
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Antiviral activities of ISG20 in positive-strand RNA virus infections
@ast
Antiviral activities of ISG20 in positive-strand RNA virus infections
@en
Antiviral activities of ISG20 in positive-strand RNA virus infections
@en-gb
Antiviral activities of ISG20 in positive-strand RNA virus infections
@nl
type
label
Antiviral activities of ISG20 in positive-strand RNA virus infections
@ast
Antiviral activities of ISG20 in positive-strand RNA virus infections
@en
Antiviral activities of ISG20 in positive-strand RNA virus infections
@en-gb
Antiviral activities of ISG20 in positive-strand RNA virus infections
@nl
prefLabel
Antiviral activities of ISG20 in positive-strand RNA virus infections
@ast
Antiviral activities of ISG20 in positive-strand RNA virus infections
@en
Antiviral activities of ISG20 in positive-strand RNA virus infections
@en-gb
Antiviral activities of ISG20 in positive-strand RNA virus infections
@nl
P2093
P2860
P921
P3181
P1433
P1476
Antiviral activities of ISG20 in positive-strand RNA virus infections
@en
P2093
Joan E Nichols
Ju-Tao Guo
Michael R Holbrook
Qingming Dong
Rene Rijnbrand
Sara E Woodson
P2860
P304
P3181
P356
10.1016/J.VIROL.2010.10.008
P407
P577
2011-01-20T00:00:00Z